Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Encephalon is a private healthcare and neuroscience research company founded by Dr. Joe Dispenza that focuses on the intersection of neuroscience, epigenetics, and quantum physics. The company conducts extensive biological research into the physiological effects of intensive meditation and mind-body interventions, utilizing advanced multi-omic, transcriptomic, and metabolomic analysis. Encephalon provides educational programs, workshops, and global retreats designed to help individuals reprogram their biological operating systems and activate internal healing mechanisms. Its business model centers on translating complex scientific findings into practical tools for personal transformation and health optimization.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Encephalon.